Stevanato Group (NYSE:STVN) Research Coverage Started at UBS Group

UBS Group started coverage on shares of Stevanato Group (NYSE:STVN) in a report released on Wednesday morning, MarketBeat Ratings reports. The firm issued a neutral rating and a $23.00 price objective on the stock.

A number of other equities analysts have also weighed in on STVN. TD Cowen upgraded Stevanato Group to a “strong-buy” rating in a research note on Wednesday, June 17th. Weiss Ratings upgraded Stevanato Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, August 27th. Finally, Wolfe Research started coverage on Stevanato Group in a report on Tuesday, June 2nd. They set an “outperform” rating and a $21.00 target price on the stock. Two equities research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy”.

Stevanato Group Stock Up 0.2%

NYSE:STVN opened at €20.98 on Wednesday. The firm has a market capitalization of $6.35 billion, a P/E ratio of 37.47, a PEG ratio of 1.72 and a beta of 0.75. Stevanato Group has a 1-year low of €12.89 and a 1-year high of €28.00. The company’s fifty day moving average price is €20.55 and its 200-day moving average price is €17.84. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.61 and a quick ratio of 1.08.

Stevanato Group (NYSE:STVN) last posted its earnings results on Wednesday, August 5th. The company reported €0.14 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of €0.15 by (€0.01). The business had revenue of €302.00 million for the quarter. Stevanato Group had a net margin of 10.99% and a return on equity of 10.43%. As a group, equities research analysts anticipate that Stevanato Group will post 0.69 EPS for the current year.

Insider Activity

In related news, Director Luciano Santel sold 2,023 shares of the firm’s stock in a transaction on Friday, August 7th. The shares were sold at an average price of €20.09, for a total transaction of €40,642.07. Following the sale, the director owned 4,739 shares in the company, valued at approximately €95,206.51. This trade represents a 29.92% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director William Federici sold 1,493 shares of Stevanato Group stock in a transaction on Monday, June 15th. The shares were sold at an average price of €17.09, for a total transaction of €25,515.37. Following the completion of the transaction, the director directly owned 26,991 shares of the company’s stock, valued at €461,276.19. The trade was a 5.24% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 14,249 shares of company stock valued at $268,346 in the last three months. Corporate insiders own 0.70% of the company’s stock.

Hedge Funds Weigh In On Stevanato Group

Several institutional investors and hedge funds have recently modified their holdings of STVN. First Bank & Trust raised its holdings in Stevanato Group by 3.4% in the 2nd quarter. First Bank & Trust now owns 18,417 shares of the company’s stock worth $333,000 after purchasing an additional 603 shares during the period. Fifth Third Bancorp grew its holdings in Stevanato Group by 22.6% in the first quarter. Fifth Third Bancorp now owns 4,196 shares of the company’s stock valued at $58,000 after purchasing an additional 773 shares during the period. GW&K Investment Management LLC grew its holdings in Stevanato Group by 76.2% in the fourth quarter. GW&K Investment Management LLC now owns 2,440 shares of the company’s stock valued at $49,000 after purchasing an additional 1,055 shares during the period. Pathstone Holdings LLC increased its position in shares of Stevanato Group by 1.5% in the third quarter. Pathstone Holdings LLC now owns 71,178 shares of the company’s stock valued at $1,833,000 after buying an additional 1,067 shares in the last quarter. Finally, Mariner LLC increased its position in shares of Stevanato Group by 6.9% in the third quarter. Mariner LLC now owns 25,447 shares of the company’s stock valued at $655,000 after buying an additional 1,638 shares in the last quarter.

Stevanato Group Company Profile

Stevanato Group S.p.A. is an Italy-based developer and manufacturer of drug-containment and drug-delivery solutions for the pharmaceutical, biotechnology and healthcare industries. The company provides products and services designed to support the development, production and administration of injectable medicines.

Its portfolio includes glass vials, cartridges and syringes, as well as other primary packaging components and containment systems. Stevanato Group also offers inspection and packaging equipment, analytical and laboratory services, and drug-delivery technologies such as prefillable syringes and combination-device solutions.